Cargando…
Concurrent Lymphoma and COVID-19: Diagnostic and Therapeutic Challenges of High-Grade Lymphoma and COVID-19
The coronavirus disease 2019 (COVID-19) global pandemic has put an unprecedented strain on cancer care. The initial months were marred by fears of immunocompromised patients becoming opportunistic hosts to this deadly virus. We present a case of newly diagnosed high-grade B-cell lymphoma in a patien...
Autores principales: | Hundal, Jasmin, Vartanov, Alexander R, Huh, Kang, Ballesteros, Enrique, Forbes, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960537/ https://www.ncbi.nlm.nih.gov/pubmed/35371790 http://dx.doi.org/10.7759/cureus.22635 |
Ejemplares similares
-
Case Report: Concurrent Occurrence of Abdominal Double Expressor Lymphoma and Jejunum Follicular Lymphoma
por: Takada, Ryutaro, et al.
Publicado: (2021) -
Psychological Distress in Outpatients With Lymphoma During the COVID-19 Pandemic
por: Romito, Francesca, et al.
Publicado: (2020) -
Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?
por: Liu, Hui, et al.
Publicado: (2021) -
Concurrent with T-zone lymphoma and high-grade gastrointestinal cytotoxic
T-cell lymphoma in a dog
por: SUWA, Akihisa, et al.
Publicado: (2017) -
Induction treatment in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: a systematic review and meta-analysis
por: Zeremski, Vanja, et al.
Publicado: (2023)